Incanthera plc — Investor Relations & Filings
Incanthera plc is a therapeutics company specializing in the discovery and development of targeted solutions for dermatology and oncology. The company develops and applies sophisticated formulation and delivery technologies to create novel treatments. Its pipeline includes clinical-stage oncology assets intended for licensing to pharmaceutical partners. Incanthera has also commercialized its dermatological expertise through its direct-to-consumer skincare brand, Skin+CELL, which is designed to address unmet needs in the skincare market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Commercial Update | 2026-03-31 | English | |
| Half-year Report | 2025-12-11 | English | |
| Aquis Showcase Investor Presentation | 2025-11-17 | English | |
| AGM 2025 Presentation Materials | 2025-11-10 | English | |
| Result of AGM | 2025-11-07 | English | |
| AGM 2025 Update | 2025-11-06 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 33101940 | Commercial Update | 2026-03-31 | English | ||
|
2025
14 filings
| |||||
| 9829217 | Half-year Report | 2025-12-11 | English | ||
| 8443828 | Aquis Showcase Investor Presentation | 2025-11-17 | English | ||
| 8169884 | AGM 2025 Presentation Materials | 2025-11-10 | English | ||
| 8136371 | Result of AGM | 2025-11-07 | English | ||
| 8117602 | AGM 2025 Update | 2025-11-06 | English | ||
| 8026824 | Proactive Investor Forum Presentation | 2025-10-16 | English | ||
| 8017517 | Notice of AGM | 2025-10-14 | English | ||
| 11393901 | Investor Presentation | 2025-10-06 | English | ||
| 11392297 | Final Results | 2025-09-30 | English | ||
| 7703853 | SKIN + CELL COMMERCIAL WEBSITE NOW OPEN FOR SALES | 2025-08-11 | English | ||
| 7653380 | SKIN + CELL TO LAUNCH | 2025-08-06 | English | ||
| 6816215 | Holding(s) in Company | 2025-07-09 | English | ||
| 6524359 | Subscription, Directors' Dealing and RPT | 2025-06-30 | English | ||
| 6184237 | New Findings on Protective Effects of Skin + CELL | 2025-06-18 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Incanthera plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Incanthera plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10290/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10290 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10290 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10290 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10290}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Incanthera plc (id: 10290)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.